Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs in the United States Edmund J. Bini, MD, MPH1, Steven Kritz, MD2, Lawrence S. Brown, Jr, MD, - PowerPoint PPT Presentation

About This Presentation
Title:

Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs in the United States Edmund J. Bini, MD, MPH1, Steven Kritz, MD2, Lawrence S. Brown, Jr, MD,

Description:

Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection, ... 1Division of Gastroenterology, VA New York Harbor Healthcare System and New York ... – PowerPoint PPT presentation

Number of Views:26
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs in the United States Edmund J. Bini, MD, MPH1, Steven Kritz, MD2, Lawrence S. Brown, Jr, MD,


1
Barriers to Providing Health Services for
HIV/AIDS, Hepatitis C Virus Infection, and
Sexually Transmitted Infections in Substance
Abuse Treatment Programs in the United
StatesEdmund J. Bini, MD, MPH1, Steven Kritz,
MD2, Lawrence S. Brown, Jr, MD, MPH2,3, Jim
Robinson, MEd4, Don Alderson, MS5, John Rotrosen,
MD61Division of Gastroenterology, VA New York
Harbor Healthcare System and New York University
School of Medicine, New York, NY 2Addiction
Research and Treatment Corporation, Brooklyn, NY
3Department of Public Health, Weill Medical
College, Cornell University, New York, NY
4Nathan Kline Institute, Orangeburg, NY 5New
York State Psychiatric Institute, New York, NY
6Department of Psychiatry, VA New York Harbor
Healthcare System and New York University School
of Medicine, New York, NY
Methods
Results
Results
Background Aim
  • To assess barriers to delivering health services
    for the 3 targeted infections, program
    administrators were provided with a list of 7
    barriers and were asked to choose yes or no for
    each of the 7 barriers to delivering each of the
    4 medical and 4 non-medical services
  • The treatment program clinician surveys were sent
    by mail to 2,210 randomly selected clinicians at
    each of the programs
  • The questions that assessed clinician barriers
    were identical to the questions in the program
    administrator survey
  • Human immunodeficiency virus (HIV), hepatitis C
    virus (HCV), and sexually transmitted infections
    (STI) are major public health problems worldwide
  • The use and abuse of illicit substances is also a
    major public health problem, and substance abuse
    is largely responsible for sustaining the
    epidemics of HIV, HCV, and STI in the United
    States
  • To date, however, the limited multicenter data
    that are available demonstrate that HIV/AIDS,
    HCV, and STI health services are not universally
    available in all drug treatment programs
  • The reasons why these services are not offered
    are unknown
  • The primary aim of this study was to determine
    barriers to offering health services for
    HIV/AIDS, HCV, and STI within substance abuse
    treatment programs in the United States

HIV/AIDS, HCV, and STI Services Offered by the
269 Substance Abuse Programs
Barriers to Providing HIV/AIDS, HCV, and STI
Services Reported by Program Administrators
HIV/AIDS Services Offered HCV Services Offered STI Services Offered P-Value
Patient medical history and physical exam 59.8 52.9 51.6 0.14
Patient biological testing 52.4 36.8 42.2 lt0.01
Patient treatment 41.5 30.8 35.8 0.04
Patient monitoring 47.4 37.5 41.2 0.08
Provider education 73.2 67.3 60.8 0.01
Patient education 89.3 78.4 80.1 lt0.01
Patient risk assessment 88.5 75.8 76.5 lt0.01
Patient counseling 71.8 62.4 63.7 0.06
Medical Services Medical Services Medical Services Medical Services Non-Medical Services Non-Medical Services Non-Medical Services Non-Medical Services
Barriers to Providing Services Patient Medical History and Physical Exam Patient Biological Testing Patient Treatment Patient Monitoring Provider Education Patient Education Patient Risk Assessment Patient Counseling
HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS
Government regulations 11.8 16.0 17.9 14.3 9.4 9.1 5.8 10.5
Treatment program policies 14.2 18.3 19.2 18.4 8.2 7.4 7.1 11.3
Staff training 27.0 29.2 34.9 34.0 41.5 39.4 32.8 39.5
Funding 56.7 63.8 70.4 64.9 64.2 58.4 47.9 62.0
Patient/client health insurance benefits 48.3 52.1 58.6 53.8 34.6 42.3 35.8 51.9
Patient/client acceptance 32.8 37.3 41.4 39.3 17.0 38.6 33.8 43.3
Staff acceptance 11.0 16.5 14.3 16.0 13.3 13.0 11.3 15.9
Other barriers 4.8 3.4 8.2 6.5 3.4 5.4 2.1 6.7
HCV HCV HCV HCV HCV HCV HCV HCV HCV
Government regulations 13.2 14.2 15.7 16.3 7.4 7.0 5.7 8.7
Treatment program policies 11.8 20.7 22.9 20.6 8.3 7.0 8.3 12.3
Staff training 27.6 31.7 39.6 36.8 41.3 44.7 36.2 43.9
Funding 55.3 65.1 71.7 63.4 65.2 61.5 48.5 60.3
Patient/client health insurance benefits 49.1 57.1 59.4 53.9 34.3 42.1 35.6 48.7
Patient/client acceptance 33.8 39.8 47.8 43.7 13.0 33.8 31.0 39.7
Staff acceptance 11.8 16.4 17.0 17.5 12.2 12.4 12.7 14.2
Other barriers 8.3 10.3 8.8 8.6 6.9 7.6 4.1 8.2
STI STI STI STI STI STI STI STI STI
Government regulations 11.7 14.7 14.2 12.3 8.1 10.3 8.2 10.8
Treatment program policies 13.7 20.3 16.4 17.8 10.2 13.2 9.4 12.0
Staff training 31.8 31.9 36.1 31.9 42.2 45.1 33.8 41.3
Funding 53.4 59.2 63.8 57.8 62.3 59.7 50.8 59.0
Patient/client health insurance benefits 47.4 53.0 55.2 50.4 32.3 41.6 36.4 49.8
Patient/client acceptance 33.8 36.2 37.4 39.5 14.8 34.8 35.5 40.9
Staff acceptance 11.7 16.5 16.0 15.8 13.3 14.2 10.3 15.5
Other barriers 6.6 6.6 6.6 6.5 6.7 4.8 5.2 7.9
Results
Median Number of the 8 Health Services Offered
for HIV/AIDS, HCV, and STI
  • Completed surveys were received from
  • 269 of the 319 program administrators (84.3)
  • 1,723 of the 2,210 clinicians (78.0)

P lt0.01
Methods
Characteristics of the 269 Substance Abuse
Programs
Characteristic Percent
Corporate structure Private not-for-profit Private for-profit Government Other 78.7 5.6 13.4 2.2
Nature of the program Hospital/Medical School/University Mental Health/Family/Child Services Center Free-Standing Other 13.9 12.7 60.7 12.7
Largest source of revenue County/local grants State funds Medicaid Federal grants Other 17.2 39.3 17.6 12.6 13.4
Addiction services offered Inpatient or residential services Outpatient pharmacotherapy Other outpatient services Outreach support services 55.0 36.8 80.2 87.6
Medical staff (MD, PA, NP, RN, LPN, etc.) 0 1 3 4 or more 21.1 36.4 42.5
Non-medical staff 0 7 8 17 18 or more 30.3 45.2 24.5
Current patient census 0 1 500 501 1,000 1,000 or more 2.0 56.9 20.4 20.8
Percent of patients infected with HIV 0 1 10 11 20 21 or more 12.4 65.7 12.4 9.6
Percent of patients infected with HCV 0 1 10 11 20 21 or more 9.2 30.1 12.1 48.6
Percent of patients infected with STI 0 1 10 11 20 21 or more 8.3 57.5 15.0 19.2
  • The target population for this study included
    treatment program administrators (program
    directors or managers) and treatment program
    clinicians in all substance abuse treatment
    programs within the National Drug Abuse Treatment
    Clinical Trials Network (CTN) in the United
    States
  • The CTN includes a large number of treatment
    programs whose mission is to improve the quality
    of drug abuse treatment throughout the country
    using evidence-based medicine and science as the
    vehicle
  • The treatment program administrator surveys were
    sent by mail to each of the administrators of the
    319 treatment programs within the CTN
  • This comprehensive survey assessed the structure
    of the treatment program, staffing, funding,
    characteristics of the patients enrolled in the
    program, services offered for HIV/AIDS, HCV, and
    STI, and barriers to offering services for these
    infections
  • For each of the 3 infections, we assessed the
    availability of 8 health services (offered either
    on-site or by contractual agreement with another
    provider), including
  • 4 medical services (medical history/physical
    examination, biological testing, medical
    treatment, medical monitoring)
  • 4 non-medical services (provider education,
    patient education, patient risk assessment,
    patient counseling)

Proportion of Programs That Did Not Offer Any of
the 4 Medical or 4 Non-Medical Services for
HIV/AIDS, HCV, and STI
No Medical Services
No Non-Medical Services
P lt0.01
P lt0.01
References
Conclusions
  • Health service delivery for HIV/AIDS, HCV, and
    STI is less than optimal in drug treatment
    programs in the United States
  • There are numerous barriers to providing these
    services
  • Public health interventions to overcome barriers
    to care afford an opportunity to enhance
    treatment and prevention of these infections
  • The frequency and types of barriers reported by
    program administrators and clinicians were
    similar
  • Only the barriers reported by the program
    administrators are presented
Write a Comment
User Comments (0)
About PowerShow.com